EG 427 Gets €27M in Series B Funding for Clinical Study
EG 427, a biotech company developing targeted genetic medicines for neurological conditions, secured €27 million in Series B funding....
eClinical Tech News
Neurona’s Epic Nrtx-1001 Cell Therapy Epilepsy Study
Neurona Therapeutics, a clinical-stage biotherapeutics company, is initiating its Phase 3 EPIC clinical trial for NRTX-1001, a regenerative cell...
Shattuck Labs Announces Positive SL-325 Data at ECCO 2025
Shattuck Labs announced positive preclinical data from a toxicology study of SL-325, a high-affinity DR3 blocking antibody being developed...
Dupixent® FDA Priority Review for Bullous Pemphigoid Treatment
Regeneron and Sanofi announced that the FDA accepted for Priority Review their supplemental Biologics License Application for Dupixent (dupilumab)...
Benitec Biopharma’s BB-301 Study at MDA Conference
Benitec Biopharma announced interim clinical study updates for the first three subjects in its Phase 1b/2a trial of BB-301,...
Next-Gen Nectin-4 Targeting ADC Shows Promise in Phase 1 Study
Corbus Pharmaceuticals announced positive data from its US and UK Phase 1 dose escalation study of CRB-701, a next-generation...
Allogene Therapeutics Publishes Durable Response Data from Phase 1 Trials of ALLO-501 in R/R LBCL
Allogene Therapeutics announced positive results from its Phase 1 ALPHA and ALPHA2 clinical trials of cema-cel, an allogeneic CAR...
BioCardia Completes Low-Dose Cohort Enrollment in CardiALLO Trial
BioCardia completed enrollment and dosing in the low-dose cohort of its CardiALLO™ Phase I/II trial. This trial investigates allogeneic...
AskBio Gene Therapy Trial for Heart Failure Begins in Europe
AskBio, a Bayer subsidiary, has initiated the European arm of its Phase 2 GenePHIT trial for AB-1002, a gene...
NKGen Biotech Publishes Promising Alzheimer’s Drug Trial Results
NKGen Biotech announced the publication of Phase 1 clinical trial results for troculeucel, an NK cell therapy for Alzheimer’s...